Simplex Trading’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,800
| Closed | -$25K | – | 9021 |
|
|
2025
Q2 | $25K | Buy |
4,800
+4,200
| +700% | +$20.4K | ﹤0.01% | 6557 |
|
|
2025
Q1 | $3K | Buy |
600
+100
| +20% | +$700 | ﹤0.01% | 7775 |
|
|
2024
Q4 | $4K | Sell |
500
-200
| -29% | -$2.12K | ﹤0.01% | 7701 |
|
|
2024
Q3 | $7K | Buy |
700
+300
| +75% | +$3.34K | ﹤0.01% | 7396 |
|
|
2024
Q2 | $3K | Sell |
400
-159,000
| -100% | -$1.55M | ﹤0.01% | 8069 |
|
|
2024
Q1 | $2.24M | Buy |
+159,400
| New | +$1.99M | ﹤0.01% | 2289 |
|
|
2023
Q2 | – | Sell |
-1,300
| Closed | -$17K | – | 8927 |
|
|
2023
Q1 | $17K | Sell |
1,300
-2,600
| -67% | -$35.2K | ﹤0.01% | 7045 |
|
|
2022
Q4 | $58K | Sell |
3,900
-7,900
| -67% | -$81.5K | ﹤0.01% | 5676 |
|
|
2022
Q3 | $106K | Buy |
11,800
+4,000
| +51% | +$26.8K | ﹤0.01% | 5433 |
|
|
2022
Q2 | $23K | Sell |
7,800
-11,800
| -60% | -$52.9K | ﹤0.01% | 7429 |
|
|
2022
Q1 | $131K | Buy |
19,600
+8,500
| +77% | +$50.6K | ﹤0.01% | 5757 |
|
|
2021
Q4 | $59K | Buy |
+11,100
| New | +$73K | ﹤0.01% | 7027 |
|
|
2021
Q3 | – | Sell |
-967
| Closed | -$12K | – | 9747 |
|
|
2021
Q2 | $12K | Buy |
967
+922
| +2,049% | +$12K | ﹤0.01% | 8965 |
|
|
2021
Q1 | $78K | Buy |
45
+42
| +1,400% | +$759 | ﹤0.01% | 6071 |
|
|
2020
Q4 | $3K | Buy |
+3
| New | +$53 | ﹤0.01% | 7851 |
|
|
2020
Q2 | – | Sell |
-2
| Closed | -$4K | – | 7565 |
|
|
2020
Q1 | $4K | Buy |
+2
| New | +$62 | ﹤0.01% | 6927 |
|
Simplex Trading's ATXS Position: Q1 2026 in Review
Simplex Trading sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 3,257 shares — an estimated $42.6K sold.
Simplex Trading first reported a position in ATXS in Q4 2020 and held it in 17 quarters. The position peaked at $1.36M in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Simplex Trading reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 3,257 Astria Therapeutics shares in Q1 2026, an estimated $42.6K.
- Simplex Trading first reported a position in Astria Therapeutics in Q4 2020 and held it in 17 quarters.
- Simplex Trading's Astria Therapeutics position peaked at $1.36M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.